RESUMO
We performed a randomised controlled trial comparing computer-assisted surgery (CAS) with conventional surgery (CONV) in total knee replacement (TKR). Between 2009 and 2011 a total of 192 patients with a mean age of 68 years (55 to 85) with osteoarthritis or arthritic disease of the knee were recruited from four Norwegian hospitals. At three months follow-up, functional results were marginally better for the CAS group. Mean differences (MD) in favour of CAS were found for the Knee Society function score (MD: 5.9, 95% confidence interval (CI) 0.3 to 11.4, p = 0.039), the Knee Injury and Osteoarthritis Outcome Score (KOOS) subscales for 'pain' (MD: 7.7, 95% CI 1.7 to 13.6, p = 0.012), 'sports' (MD: 13.5, 95% CI 5.6 to 21.4, p = 0.001) and 'quality of life' (MD: 7.2, 95% CI 0.1 to 14.3, p = 0.046). At one-year follow-up, differences favouring CAS were found for KOOS 'sports' (MD: 11.0, 95% CI 3.0 to 19.0, p = 0.007) and KOOS 'symptoms' (MD: 6.7, 95% CI 0.5 to 13.0, p = 0.035). The use of CAS resulted in fewer outliers in frontal alignment (> 3° malalignment), both for the entire TKR (37.9% vs. 17.9%, p = 0.042) and for the tibial component separately (28.4% vs 6.3%, p = 0.002). Tibial slope was better achieved with CAS (58.9% vs. 26.3%, p < 0.001). Operation time was 20 minutes longer with CAS. In conclusion, functional results were, statistically, marginally in favour of CAS. Also, CAS was more predictable than CONV for mechanical alignment and positioning of the prosthesis. However, the long-term outcomes must be further investigated.
Assuntos
Artroplastia do Joelho/métodos , Cirurgia Assistida por Computador/métodos , Idoso , Idoso de 80 Anos ou mais , Artroplastia do Joelho/efeitos adversos , Artroplastia do Joelho/reabilitação , Mau Alinhamento Ósseo/etiologia , Mau Alinhamento Ósseo/prevenção & controle , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Articulação do Joelho/fisiopatologia , Prótese do Joelho , Masculino , Pessoa de Meia-Idade , Osteoartrite do Joelho/cirurgia , Ajuste de Prótese/métodos , Amplitude de Movimento Articular , Recuperação de Função Fisiológica , Cirurgia Assistida por Computador/efeitos adversos , Cirurgia Assistida por Computador/reabilitação , Resultado do TratamentoRESUMO
We evaluated the rates of survival and cause of revision of seven different brands of cemented primary total knee replacement (TKR) in the Norwegian Arthroplasty Register during the years 1994 to 2009. Revision for any cause, including resurfacing of the patella, was the primary endpoint. Specific causes of revision were secondary outcomes. Three posterior cruciate-retaining (PCR) fixed modular-bearing TKRs, two fixed non-modular bearing PCR TKRs and two mobile-bearing posterior cruciate-sacrificing TKRs were investigated in a total of 17 782 primary TKRs. The median follow-up for the implants ranged from 1.8 to 6.9 years. Kaplan-Meier 10-year survival ranged from 89.5% to 95.3%. Cox's relative risk (RR) was calculated relative to the fixed modular-bearing Profix knee (the most frequently used TKR in Norway), and ranged from 1.1 to 2.6. The risk of revision for aseptic tibial loosening was higher in the mobile-bearing LCS Classic (RR 6.8 (95% confidence interval (CI) 3.8 to 12.1)), the LCS Complete (RR 7.7 (95% CI 4.1 to 14.4)), the fixed modular-bearing Duracon (RR 4.5 (95% CI 1.8 to 11.1)) and the fixed non-modular bearing AGC Universal TKR (RR 2.5 (95% CI 1.3 to 5.1)), compared with the Profix. These implants (except AGC Universal) also had an increased risk of revision for femoral loosening (RR 2.3 (95% CI 1.1 to 4.8), RR 3.7 (95% CI 1.6 to 8.9), and RR 3.4 (95% CI 1.1 to 11.0), respectively). These results suggest that aseptic loosening is related to design in TKR.
Assuntos
Artroplastia do Joelho , Articulação do Joelho/cirurgia , Prótese do Joelho , Idoso , Idoso de 80 Anos ou mais , Artroplastia do Joelho/efeitos adversos , Cimentos Ósseos , Feminino , Humanos , Prótese do Joelho/efeitos adversos , Masculino , Pessoa de Meia-Idade , Desenho de Prótese , Falha de Prótese , Sistema de Registros , ReoperaçãoRESUMO
To determine whether systemic immunization with plasmid DNA and virus vector against visna/maedi virus (VMV) would induce protective immune responses, sheep were immunized with VMV gag and/or env sequences using particle-mediated epidermal bombardment and injection of recombinant modified vaccinia Ankara. The results showed that immunization induced both humoral and cell-mediated responses prior to and after virus challenge. The vaccination protocol did not prevent infection, but immunization with the gag gene or a combination of gag and env genes resulted in significantly reduced provirus loads in blood and mediastinal lymph node, respectively. Provirus loads in lung and draining lymph node were unaffected, but p25 expression was undetectable in lungs of animals immunized with a combination of gag and env genes. Analysis of target tissues for lesions at post-mortem showed that immunization with the env gene caused a significant increase in lesion score, while the gag gene or a combination of gag and env genes had no effect. Inclusion of the ovine interferon-gamma gene in the initial priming mixture had minimal effect on immune responses, provirus load, or lesion development, although it resulted in a decreased p25 expression in the lung. The results thus show that systemic immunization with gag or a combination of gag and env genes reduces provirus load in blood and lymphoid tissue, respectively whereas env immunization has no effect on provirus load but increased lesion development.
Assuntos
Biolística , Genes env/genética , Genes gag/genética , Pneumonia Intersticial Progressiva dos Ovinos/prevenção & controle , Vacinas de DNA , Vaccinia virus/genética , Animais , Anticorpos Antivirais/sangue , Epiderme/virologia , Feminino , Genes env/imunologia , Genes gag/imunologia , Imunização , Masculino , Pneumonia Intersticial Progressiva dos Ovinos/virologia , Provírus/isolamento & purificação , Ovinos , Linfócitos T/imunologia , Vacinas de DNA/administração & dosagem , Vacinas de DNA/genética , Vacinas de DNA/imunologia , Vaccinia virus/imunologia , Vacinas Virais/administração & dosagem , Vacinas Virais/genética , Vacinas Virais/imunologia , Vírion/genética , Vírion/imunologia , Vírus Visna-MaediRESUMO
Sheep were immunized against Visna/Maedi virus (VMV) gag and/or env genes via the nasopharynx-associated lymphoid tissue (NALT) and lung using polyethylenimine (PEI)-DNA complexes and modified vaccinia Ankara, and challenged with live virus via the lung. env immunization enhanced humoral responses prior to but not after VMV challenge. Systemic T cell proliferative and cytotoxic responses were generally low, with the responses following single gag gene immunization being significantly depressed after challenge. A transient reduction in provirus load in the blood early after challenge was observed following env immunization, whilst the gag gene either alone or in combination with env resulted in significantly elevated provirus loads in lung. However, despite this, a significant reduction in lesion score was observed in animals immunized with the single gag gene at post-mortem. Inclusion of IFN-gamma in the immunization mixture in general had no significant effects. The results thus showed that protective effects against VMV-induced lesions can be induced following respiratory immunization with the single gag gene, though this was accompanied by an increased pulmonary provirus load.
Assuntos
Produtos do Gene env/imunologia , Produtos do Gene pol/imunologia , Pneumonia Intersticial Progressiva dos Ovinos/prevenção & controle , Vacinas de DNA/imunologia , Vacinas Virais/imunologia , Vírus Visna-Maedi/imunologia , Animais , Anticorpos Antivirais/sangue , Proliferação de Células , Testes Imunológicos de Citotoxicidade , Feminino , Produtos do Gene env/genética , Produtos do Gene pol/genética , Vetores Genéticos , Leucócitos Mononucleares/imunologia , Pulmão/imunologia , Pulmão/patologia , Pulmão/virologia , Masculino , Nasofaringe/imunologia , Provírus/isolamento & purificação , Índice de Gravidade de Doença , Ovinos , Linfócitos T Citotóxicos/imunologia , Vacinas de DNA/administração & dosagem , Vaccinia virus/genética , Carga Viral , Vacinas Virais/administração & dosagemRESUMO
Maedi-visna virus (MVV) spreads horizontally via the respiratory route. In order to establish an experimental mucosal infection route, we compared intranasal and intratracheal inoculation using the infectious MVV molecular clone KV1772-kv72/67. For intranasal infection 0.5 x 10(3)-0.5 x 10(7) TCID50 of virus was sprayed into the nostrils of the sheep. For the intratracheal infection 10(0)-10(6) TCID50 of virus was injected into the trachea. Successful infection was indicated by development of MVV specific antibodies and virus isolation over a period of 6 months. In the intranasal infection, only the sheep receiving the highest dose i.e., 0.5 x 10(7) TCID50, became infected, suggesting that intranasal application was not an efficient mode of infection. In the intratracheal infection, the sheep infectious dose 50% was 10(1) TCID50 and virus could be isolated from the central nervous system 4 months post infection with 10(4) TCID50. Therefore it is concluded that intratracheal infection is a very efficient route for experimental inoculation with MVV.
Assuntos
Pneumonia Intersticial Progressiva dos Ovinos/virologia , Doenças dos Ovinos/virologia , Vírus Visna-Maedi/crescimento & desenvolvimento , Administração Intranasal , Animais , Anticorpos Antivirais/sangue , Ensaio de Imunoadsorção Enzimática/veterinária , Pneumonia Intersticial Progressiva dos Ovinos/sangue , Pneumonia Intersticial Progressiva dos Ovinos/transmissão , Ovinos , Traqueia/virologiaRESUMO
Painful bilateral ophthalmoparesis, marked proptosis, increased intraocular pressure, and blindness developed in a 29-year-old woman with protein C deficiency and catastrophic antiphospholipid syndrome. Magnetic resonance imaging of the orbits showed bilateral proptosis, globe tenting, and tethering of the optic nerves consistent with an orbital ischemic syndrome. Despite aggressive therapy for antiphospholipid syndrome, the patient died. The autopsy showed necrosis of orbital tissues. This is the first report of orbital ischemic syndrome from protein C deficiency and antiphospholipid syndrome.
Assuntos
Síndrome Antifosfolipídica/complicações , Isquemia/etiologia , Órbita/irrigação sanguínea , Adulto , Síndrome Antifosfolipídica/diagnóstico , Cegueira/etiologia , Exoftalmia/etiologia , Evolução Fatal , Feminino , Humanos , Pressão Intraocular , Isquemia/diagnóstico , Imageamento por Ressonância Magnética , Oftalmoplegia/etiologia , Deficiência de Proteína C/complicações , Deficiência de Proteína C/diagnóstico , SíndromeRESUMO
OBJECTIVE: To estimate the frequency, duration, and clinical importance of postherpetic neuralgia after a single episode of herpes zoster. DESIGN: Prospective cohort study with long term follow up. SETTING: Primary health care in Iceland. PARTICIPANTS: 421 patients with a single episode of herpes zoster. MAIN OUTCOME MEASURES: Age and sex distribution of patients with herpes zoster, point prevalence of postherpetic neuralgia, and severity of pain at 1, 3, 6, and 12 months and up to 7.6 years after the outbreak of zoster. RESULTS: Among patients younger than 60 years, the risk of postherpetic neuralgia three months after the start of the zoster rash was 1.8% (95% confidence interval 0.59% to 4.18%) and pain was mild in all cases. In patients 60 years and older, the risk of postherpetic neuralgia increased but the pain was usually mild or moderate. After three months severe pain was recorded in two patients older than 60 years (1.7%, 2.14% to 6.15%). After 12 months no patient reported severe pain and 14 patients (3.3%) had mild or moderate pain. Seven of these became pain free within two to seven years, and five reported mild pain and one moderate pain after 7.6 years of follow up. Sex was not a predictor of postherpetic neuralgia. Possible immunomodulating comorbidity (such as malignancy, systemic steroid use, diabetes) was present in 17 patients. CONCLUSIONS: The probability of longstanding pain of clinical importance after herpes zoster is low in an unselected population of primary care patients essentially untreated with antiviral drugs.
Assuntos
Herpes Zoster/complicações , Neuralgia/virologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Antivirais/uso terapêutico , Criança , Pré-Escolar , Feminino , Seguimentos , Herpes Zoster/tratamento farmacológico , Herpes Zoster/epidemiologia , Humanos , Islândia/epidemiologia , Lactente , Masculino , Pessoa de Meia-Idade , Neuralgia/epidemiologia , Neuralgia/prevenção & controle , Prevalência , Estudos Prospectivos , Recidiva , Distribuição por SexoRESUMO
OBJECTIVES: To follow the clinical course of herpes zoster and to determine the incidence, frequency of complications and association with malignancy in children and adolescents. DESIGN: Prospective cohort study in a primary health care setting in Iceland. The main outcome measures were age and sex distribution of patients and discomfort or pain 1, 3 and 12 months after the rash and general health before and 3 to 6 years after the zoster episode. RESULTS: During observation of the target population for a period of 75750 person years, 121 episodes of acute zoster developed (incidence 1.6/1000/year) in 118 patients. End points were gained for all 118 patients after 554 person years of follow-up. Systemic acyclovir was never used. No patient developed postherpetic neuralgia, moderate or severe pain or any pain lasting longer than 1 month from start of the rash (95% confidence interval, 0 to 0.03). Potential immunomodulating conditions were diagnosed in 3 patients (2.5%) within 3 months of contracting zoster. Only 5 (4%) had a history of severe diseases. CONCLUSIONS: The probability of postherpetic neuralgia in children and adolescents is extremely low. Zoster is seldom associated with undiagnosed malignancy in the primary care setting.
Assuntos
Herpes Zoster/epidemiologia , Adolescente , Criança , Pré-Escolar , Feminino , Herpes Zoster/complicações , Humanos , Islândia/epidemiologia , Incidência , Lactente , Masculino , Estudos ProspectivosRESUMO
During the epidemic caused by maedi-visna virus (MVV) of sheep in Iceland, the pulmonary affection, maedi, was the predominant clinical manifestation. In some flocks, however, a central nervous system (CNS) affection, visna, was the main cause of morbidity and mortality. As there is only one breed of sheep in the country, host factors did apparently not play an important role in the different clinical manifestations. To obtain some information on possible viral genetic determinants of neurotropism and neurovirulence we studied both phenotypic and genotypic properties of two maedi-visna virus strains; a strain that was originally isolated from the brain of sheep with encephalitis (visna), and another strain isolated from the lungs of a sheep suffering from pneumonia (maedi). The brain isolate was found to grow faster in sheep choroid plexus cells than the lung isolate, whereas the growth rate in macrophages was similar for the maedi and visna virus strains. Intracerebral inoculation indicated that the visna virus isolate induced more severe brain lesions than the maedi isolate. In addition, a pathogenic molecular clone derived from a visna strain (KV1772kv72/67) was tested for growth in sheep choroid plexus cells and macrophages. The molecularly cloned virus retained the fast growth rate in choroid plexus cells. The nucleotide sequence of the env gene and the U3 of the LTR was determined for the maedi strain and compared to that of the visna strains. There was an 11.7% difference in deduced amino acid sequence in the Env protein and a 6% difference in the LTR. The molecular clone KV1772kv72/67 will be a useful reagent for characterization of viral determinants of cell tropism in vitro and possibly neurovirulence in vivo.
Assuntos
Encéfalo/virologia , Pulmão/virologia , Pneumonia Intersticial Progressiva dos Ovinos/virologia , Vírus Visna-Maedi/genética , Visna/virologia , Sequência de Aminoácidos , Animais , Sequência de Bases , Encéfalo/patologia , Linhagem Celular , DNA Viral , Feminino , Genes env , Injeções , Pulmão/patologia , Macrófagos/virologia , Dados de Sequência Molecular , Pneumonia Intersticial Progressiva dos Ovinos/patologia , Sequências Repetitivas de Ácido Nucleico , Ovinos , Visna/patologia , Vírus Visna-Maedi/crescimento & desenvolvimentoRESUMO
The major part of the dUTPase-encoding region of the visna virus genome was deleted. Intracerebral injection of the mutant virus resulted in a somewhat reduced viral load compared to that resulting from injection of the wild type, especially in the lungs, but the neuropathogenic effects were comparable. The dUTPase gene is dispensable for induction of lesions in the brain.
Assuntos
Sistema Nervoso/virologia , Pirofosfatases/genética , Vírus Visna-Maedi/genética , Visna/virologia , Animais , Deleção de Genes , Sistema Nervoso/patologia , Ovinos , Virulência/genética , Vírus Visna-Maedi/patogenicidadeRESUMO
The behavior of two genetically different molecular clones of visna virus KV1772-kv72/67 and LV1-1KS1 was compared in vivo and in vitro. On intracerebral inoculation, clone KV1772-kv72/67 induced a similar response in five sheep as has already been reported with neurovirulent derivates of visna virus. Virus was frequently isolated from blood, cerebrospinal fluid (CSF), and lymphoid organs and induced characteristic central nervous system (CNS) lesions. A strong humoral immune response was detected by ELISA, immunoblotting, and neutralization. Six sheep infected with clone LV1-1KS1 showed a completely different picture. No virus could be isolated from blood or CSF during 6 months of infection. At sacrifice all organs were virus-negative except the CNS of one sheep. None of the six sheep developed significant neutralizing antibodies and only low titer antibodies were detected by ELISA and immunoblotting. Minimal CNS lesions were present in one sheep. The molecular clones were also tested in sheep choroid plexus cells (SCP) and macrophages. In macrophages LV1-1KS1 replicated to a significantly lower titer but induced much more cell fusion than KV1772-kv72/67. The clones replicated equally well in SCP cells. Thus, these molecular clones of visna virus, which differ only by 1% in nucleotide sequence, showed a profound difference in replication and pathogenicity both in vitro and in vivo. These results can be used to map viral genetic determinants important for host-lentivirus interactions.
Assuntos
Macrófagos/virologia , Vírus Visna-Maedi/patogenicidade , Visna/virologia , Animais , Anticorpos Antivirais/sangue , Linhagem Celular , Macrófagos/citologia , Ovinos , Visna/imunologia , Visna/patologia , Vírus Visna-Maedi/imunologia , Vírus Visna-Maedi/isolamento & purificaçãoRESUMO
The virion-associated dUTPase activities of caprine arthritis-encephalitis virus (CAEV) and visna virus were determined by using an assay which measure the actual ability of the dUTPase to prevent the dUTP misincorporations into cDNA during reverse transcription. We showed that the CAEV molecular clone from the Cork isolate was dUTPase defective as a result of a single amino acid substitution. Using this point mutant and deletion mutants of CAEV as well as a deletion mutant of visna virus, we demonstrated that dUTPase-deficient viruses replicate similarly to wild-type viruses in dividing cells but show delayed replication in nondividing primary macrophages.
Assuntos
Vírus da Artrite-Encefalite Caprina/fisiologia , Pirofosfatases/metabolismo , Replicação Viral/fisiologia , Vírus Visna-Maedi/fisiologia , Animais , Vírus da Artrite-Encefalite Caprina/enzimologia , Sequência de Bases , Células Cultivadas , DNA Viral , Humanos , Macrófagos/citologia , Dados de Sequência Molecular , Mutação , Pirofosfatases/genética , Homologia de Sequência de Aminoácidos , Nucleotídeos de Timina/metabolismo , Vírus Visna-Maedi/enzimologiaRESUMO
The time course and titers of antibodies did not correlate with the severity of CNS lesions whereas the CMI did, indicating that CMI may play an important role in lesion development. The correlation of the number of CD8 positive cells in the CSF with the severity of lesions and the reversed ratio of CD4/CD8 positive cells in the diffusely infiltrated neuroparenchyma indicates that the CD8 positive T cells may be an important effector cell in the induction of CNS lesions.
Assuntos
Encéfalo/patologia , Doenças do Sistema Nervoso Central/veterinária , Visna/patologia , Animais , Relação CD4-CD8 , Doenças do Sistema Nervoso Central/imunologia , Doenças do Sistema Nervoso Central/patologia , Imunidade Celular , Subpopulações de Linfócitos , Ovinos , Visna/sangue , Visna/líquido cefalorraquidiano , Visna/imunologiaAssuntos
Ciclosporina/uso terapêutico , Visna/tratamento farmacológico , Animais , Linfócitos B , Encefalopatias/tratamento farmacológico , Encefalopatias/patologia , Encefalopatias/veterinária , Ciclosporina/sangue , Tecido Linfoide/patologia , Radioimunoensaio/veterinária , Ovinos , Linfócitos T , Visna/patologiaRESUMO
There are several indications that central nervous system (CNS) lesions in visna are immune-mediated and that cell-mediated immunity (CMI) may be of importance in the initiation of the lesions. To study the role of CMI in the pathogenesis of CNS lesions, five sheep were infected by intracerebral inoculation with visna virus and observed for 1 year. The following parameters were monitored at regular intervals: (1) neutralizing and ELISA antibodies; (2) visna virus-specific stimulation of lymphocytes from peripheral blood; (3) lymphocyte subpopulations in peripheral blood, cerebrospinal fluid (CSF) and brain at sacrifice. The CNS lesions were graded and compared with other parameters. The time course and titers of antibodies did not correlate with the severity of CNS lesions whereas the CMI did, indicating that CMI may play an important role in lesion development. The correlation of the number of CD8-positive cells in the CSF with the severity of lesions and the reversed ratio of CD4/CD8-positive cells in the diffusely infiltrated neuroparenchyma indicates that the CD8-positive T lymphocyte may be an important effector cell in the induction of CNS lesions.
Assuntos
Anticorpos Antivirais/sangue , Encéfalo/patologia , Subpopulações de Linfócitos T/imunologia , Vírus Visna-Maedi/imunologia , Visna/imunologia , Animais , Encéfalo/imunologia , Relação CD4-CD8 , Líquido Cefalorraquidiano/citologia , Antígenos de Histocompatibilidade Classe I/análise , Antígenos de Histocompatibilidade Classe II/análise , Imunidade Celular , Ovinos , Visna/patologiaRESUMO
Visna, a lingering meningo-encephalitis in sheep, was one of the diseases on which B. Sigurdsson based his theory of a special group of disorders called slow infections. The cause of the disease, a retrovirus, was isolated in 1957. Visna is now classified in a subgroup of retroviridae, lentivirinae, together with virus types in animals and the human immune deficiency virus HIV. Notwithstanding that Visna has been eradicated among Icelandic sheep for 25 years research into this virus continues since it bears many similarities to HIV and also MS.
Assuntos
HIV/classificação , Vírus Visna-Maedi/classificação , Variação Antigênica , HIV/genética , HIV/imunologia , Proteínas Virais , Cultura de Vírus , Vírus Visna-Maedi/genética , Vírus Visna-Maedi/imunologiaRESUMO
Maedi-visna virus (MVV) of sheep was the first lentivirus to be isolated. The genomic organization of MVV is very similar to that of human immunodeficiency virus (HIV) with several genes regulating the expression of the viral genome. Viral replication is severely restricted in the host and some cells apparently contain the genetic information in a DNA provirus form with little or no expression of viral antigens. This seems to be a major factor in causing the "slowness" of lentiviral infections and the persistence of the virus in the host since the immune system may not recognize the provirus-containing cells. The target cells for HIV and MVV are similar although T4 lymphocytes are not specifically destroyed in maedi-visna. There are also certain similarities in the pathological changes in both diseases, both in the central nervous system, the lungs and the lymphatic system. Although the severe final immunodeficiency state characteristic of AIDS has not been observed in maedi-visna, the basic biological features of the MVV and its interaction with host cells are so similar to HIV infection, that we consider ovine maedi-visna useful animal model for the human lentivirus infections.
Assuntos
Síndrome da Imunodeficiência Adquirida , HIV , Pneumonia Intersticial Progressiva dos Ovinos/microbiologia , Vírus Visna-Maedi , Visna/microbiologia , Síndrome da Imunodeficiência Adquirida/complicações , Síndrome da Imunodeficiência Adquirida/imunologia , Síndrome da Imunodeficiência Adquirida/microbiologia , Animais , Anticorpos Antivirais/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/microbiologia , Modelos Animais de Doenças , HIV/genética , HIV/fisiologia , Humanos , Infecções Oportunistas , Pneumonia Intersticial Progressiva dos Ovinos/complicações , Pneumonia Intersticial Progressiva dos Ovinos/imunologia , Ovinos , Visna/complicações , Visna/imunologia , Vírus Visna-Maedi/genética , Vírus Visna-Maedi/imunologia , Vírus Visna-Maedi/isolamento & purificação , Vírus Visna-Maedi/fisiologia , Vírus Visna-Maedi/ultraestruturaRESUMO
A multi-site, open-labeled clinical trial was conducted to evaluate the ease of use and acceptance of a newly developed medication cap with a memory aid (C Cap Compliance Cap, Allergan, Inc.) and its effect on patient compliance and intraocular pressure. One-hundred-twenty-two patients with glaucoma or ocular hypertension received their prescribed eye drops in bottles with the compliance cap. Overall, 83% of the patients found the compliance cap very easy to use. By the end of the study, significantly more patients (67%) claimed 100% compliance than prior to using the compliance cap (41%). An overall drop in intraocular pressure of 0.8 mm Hg was seen. However, in a subset of patients who reported an increase in compliance, mean intraocular pressure decreased from baseline by 1.7 mm Hg. The results of this study suggest that the compliance cap helps patients with glaucoma or ocular hypertension remember to take their medication as prescribed.